<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pediatr Pharmacol Ther</journal-id><journal-id journal-id-type="iso-abbrev">J Pediatr Pharmacol Ther</journal-id><journal-id journal-id-type="pmc-domain-id">1334</journal-id><journal-id journal-id-type="pmc-domain">jppt</journal-id><journal-id journal-id-type="publisher-id">jppt</journal-id><journal-title-group><journal-title>The Journal of Pediatric Pharmacology and Therapeutics : JPPT</journal-title></journal-title-group><issn pub-type="ppub">1551-6776</issn><issn pub-type="epub">2331-348X</issn><publisher><publisher-name>Pediatric Pharmacology Advocacy Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11163912</article-id><article-id pub-id-type="pmcid-ver">PMC11163912.1</article-id><article-id pub-id-type="pmcaid">11163912</article-id><article-id pub-id-type="pmcaiid">11163912</article-id><article-id pub-id-type="pmid">38863854</article-id><article-id pub-id-type="doi">10.5863/1551-6776-29.3.215</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Education</subject></subj-group></article-categories><title-group><article-title>Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Stutzman</surname><given-names initials="DL">Danielle L.</given-names></name><degrees>PharmD</degrees><xref rid="aff1" ref-type="aff"/><xref rid="aff2" ref-type="aff"/><xref rid="aff3" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dopheide</surname><given-names initials="JA">Julie A.</given-names></name><degrees>PharmD</degrees><xref rid="aff4" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Pediatric Mental Health Institute (DLS), Children&#8217;s Hospital Colorado, Aurora, CO</aff><aff id="aff2">Department of Clinical Pharmacy (DLS), University of Colorado Skaggs School of Pharmacy &amp; Pharmaceutical Sciences, Aurora, CO</aff><aff id="aff3">Department of Child and Adolescent Psychiatry (DLS), University of Colorado School of Medicine, Aurora, CO</aff><aff id="aff4">University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences and Keck School of Medicine (JAD), LAC+USC Medical Center, Los Angeles, CA</aff><author-notes><corresp id="cor1"><bold>Correspondence.</bold> Danielle L. Stutzman, PharmD; <email>danielle.stutzman@childrenscolorado.org</email></corresp><fn fn-type="COI-statement"><p><bold>Disclosure.</bold> The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript including grants, equipment, medications, employment, gifts, and honoraria.</p></fn></author-notes><pub-date pub-type="ppub" iso-8601-date="2024-06-01"><month>6</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-06-10"><day>10</day><month>6</month><year>2024</year></pub-date><volume>29</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">464604</issue-id><fpage>215</fpage><lpage>231</lpage><history><date date-type="received"><day>3</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>4</day><month>9</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>11</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-21 15:25:25.913"><day>21</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement><bold>Copyright.</bold> Pediatric Pharmacy Association. All rights reserved. For permissions, email: <email>membership@pediatricpharmacy.org</email></copyright-statement><copyright-year>2024</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="i2331-348X-29-3-215.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="i2331-348X-29-3-215.pdf"/><abstract><p>Over half of youth with attention-deficit/hyperactivity disorder (ADHD) have co-occurring psychiatric or medical conditions that present treatment challenges. Stimulants are the most effective pharmacologic treatment of ADHD for preschoolers to adults but questions about safety with co-occurring conditions frequently arise. In addition, stigma surrounding diagnosis and treatment can negatively impact care. This manuscript presents evidence-based practice pearls to guide treatment decisions for youth with ADHD and common coexisting psychiatric and medical conditions. Recommendations address specific stimulant adverse effects (i.e., anxiety, cardiac, growth, mania, psychosis) along with management strategies. Pearls were developed for the most common clinical questions, controversial topics, or therapeutic issues that may not be widely known. The goals of this manuscript are to: 1) provide a detailed resource for interprofessional teams regarding stimulant use in youth with ADHD, 2) improve therapeutic outcomes for youth with ADHD and co-occurring psychiatric and/or medical conditions through evidence-based recommendations, and 3) decrease stigma associated with stimulant use through education.</p></abstract><kwd-group><kwd>adolescent psychiatry</kwd><kwd>attention deficit hyperactivity disorder</kwd><kwd>central nervous system &#173;stimulants</kwd><kwd>child psychiatry</kwd><kwd>pediatric</kwd><kwd>psychiatrist</kwd><kwd>psychopharmacology</kwd></kwd-group><counts><page-count count="17"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>